Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00819026 · ClinicalTrials.gov registry record
Observational Trial of Hepatitis C Virus Infected Patients on Calcineurin Inhibitors
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 15
- Enrollment target
NCT00819026: Completed study, sponsored by University of Wisconsin, Madison.
NCT00819026 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00819026 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
Hepatitis C Virus is constantly evolving genetically, particularly in response to the immune system. This is an observational study to examine if immunosuppressants particularly calcineurin inhibitors taken by transplant patients in order to avoid organ rejection causes predictable changes in the genetics of this virus that might be important in order to treat it effectively.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2008-10 |
| Est. Completion | 2013-08 |
What the finished NCT00819026 record still lists
NCT00819026 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00819026 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00819026 about?
NCT00819026 is a clinical study titled "Observational Trial of Hepatitis C Virus Infected Patients on Calcineurin Inhibitors". Hepatitis C Virus is constantly evolving genetically, particularly in response to the immune system. This is an observational study to examine if immunosuppressants particularly calcineurin inhibitors taken by transplant patients in order to avoid organ rejection causes predictable changes in the ge...
What is the current status of trial NCT00819026?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2008-10. Estimated completion is 2013-08.
Who is sponsoring clinical trial NCT00819026?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia